Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
992.8 INR | +1.08% | -0.50% | +44.00% |
02:02am | Zydus Lifesciences Gets US FDA Nod to Market Dexamethasone Tablets | MT |
10/05 | India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says | RE |
End-of-day quotes
Sector Generic Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
11.83B | ||||||
43.27B | ||||||
22.92B | ||||||
15.43B | ||||||
12.95B | ||||||
6.91B |